The global digital PCR market is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022-2032.

1. 1
All rights reserved at BIS Research Inc.
G
l
o
b
a
l
D
i
g
i
t
a
l
P
C
R
M
a
r
k
e
t
res
Focus on Product, Application Type, End
User, and Region
Analysis and Forecast: 2022-2032
August 2022
Global Digital
PCR Market -
A Region and
Country Analysis
Table of Content

2. 2
All rights reserved at BIS Research Inc.
G
l
o
b
a
l
D
i
g
i
t
a
l
P
C
R
M
a
r
k
e
t
BIS Research is a leading market intelligence and technology research company. BIS Research publishes in-
depth market intelligence reports focusing on the market estimations, technology analysis, emerging high-
growth applications, deeply segmented granular country-level market data and other important market
parameters useful in the strategic decision making for senior management. BIS Research provides multi-client
reports, company profiles, databases, and custom research services.
Copyright © 2022 BIS Research Inc.
All Rights Reserved. This document contains highly confidential information and is the sole property of BIS
Research. Disclosing, copying, circulating, quoting, or otherwise reproducing any or all contents of this
document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people
or organization concerned. It may not be accessed by or offered whether for sale or otherwise to any third
party.

3. 3
All rights reserved at BIS Research Inc.
G
l
o
b
a
l
D
i
g
i
t
a
l
P
C
R
M
a
r
k
e
t
Table of Content
Executive Summary..........................................................................19
1. Markets .....................................................................................23
1.1 Product Definition .......................................................................................24
1.1.1 Inclusion and Exclusion .............................................................................24
1.2 Market Scope...............................................................................................25
1.2.1 Scope of Work .............................................................................................25
1.2.2 Key Questions Answered in the Report ....................................................26
2. Research Methodology ..............................................................27
2.1 Global Digital PCR Market: Research Methodology.................................28
2.2 Data Sources ...............................................................................................28
2.2.1 Primary Data Sources .................................................................................28
2.2.2 Secondary Data Sources ............................................................................29
2.3 Market Estimation Model ............................................................................30
2.4 Criteria for Company Profiling ...................................................................32
3. Market Overview........................................................................33
3.1 Market Definition .........................................................................................34
3.2 d-PCR vs. qPCR..........................................................................................34
3.3 Market Footprint and Growth Potential .....................................................35
3.4 COVID-19 Impact on the Global Digital PCR Market ................................36
3.4.1 Impact on Research and Clinical Operations ...........................................36
3.4.2 Impact on Market Players ...........................................................................37
3.4.3 Impact on Market Growth ...........................................................................38
4. Industry Analysis ......................................................................39
4.1 Overview ......................................................................................................40
4.1.1 Regulatory Framework in the U.S. .............................................................40
4.1.2 Regulatory Framework in European Union (EU).......................................41

4. 4
All rights reserved at BIS Research Inc.
G
l
o
b
a
l
D
i
g
i
t
a
l
P
C
R
M
a
r
k
e
t
4.1.3 Regulatory Framework in Asia-Pacific ......................................................42
4.1.3.1 Japan................................................................................................................. 42
4.1.3.2 China ................................................................................................................. 43
4.2 Patent Analysis............................................................................................44
4.2.1 Patent Analysis (by Region) .......................................................................45
4.2.2 Patent Analysis (by Country) .....................................................................45
4.2.3 Patent Analysis (by Year) ...........................................................................46
5. Market Dynamics .......................................................................47
5.1 Overview ......................................................................................................48
5.2 Impact Analysis...........................................................................................48
5.2.1 Market Drivers .............................................................................................49
5.2.1.1 Technological Transformations Related to Digital PCR..................................... 49
5.2.1.2 Rising Adoption of Digital PCR among Various Applications ............................ 50
5.2.1.3 Increasing Activities in d-PCR Ecosystem......................................................... 52
5.2.2 Market Restraints ........................................................................................53
5.2.2.1 Higher Cost of Droplet Digital PCR.................................................................... 53
5.2.2.2 Presence of Opaque Regulatory Framework .................................................... 53
5.2.3 Market Opportunities ..................................................................................54
5.2.3.1 Extensive Adoption of Genetic Testing, especially in Developing Nations ........ 54
5.2.3.2 Increasing Adoption of d-PCR in Chronic Disease Diagnosis ........................... 54
6. Competitive Landscape.............................................................56
6.1 Competitive Landscape ..............................................................................57
6.1.1 Mergers and Acquisitions...........................................................................58
6.1.2 Synergistic Activities ..................................................................................58
6.1.3 Product Launch and Approval Activities ..................................................59
6.1.4 Expansion, Funding, and Other Activities ................................................60
6.1.5 Market-Share Analysis................................................................................61
6.1.6 Growth-Share Analysis...............................................................................62

5. 5
All rights reserved at BIS Research Inc.
G
l
o
b
a
l
D
i
g
i
t
a
l
P
C
R
M
a
r
k
e
t
6.1.6.1 Growth-Share Analysis (by Company) .............................................................. 62
6.1.6.2 Growth-Share Analysis (by Application Type) ................................................... 63
6.2 Supply Chain Analysis................................................................................64
7. Product.....................................................................................66
7.1 Overview ......................................................................................................67
7.1.1 Systems........................................................................................................68
7.1.1.1 Droplet Digital PCR Systems............................................................................. 70
7.1.1.2 Chip-Based Digital PCR Systems...................................................................... 72
7.1.2 Kits and Assays...........................................................................................74
7.1.2.1 Droplet Digital PCR Systems............................................................................. 77
7.1.2.2 Chip-Based Digital PCR .................................................................................... 77
7.1.3 Reagents and Consumables ......................................................................78
7.1.3.1 Droplet Digital PCR............................................................................................ 80
7.1.3.2 Chip-Based Digital PCR .................................................................................... 80
8. Application Type .......................................................................81
8.1 Overview ......................................................................................................82
8.1.1 Oncology......................................................................................................83
8.1.1.1 Solid Tumor ....................................................................................................... 85
8.1.1.2 Hematological Malignancies.............................................................................. 86
8.1.2 Infectious Diseases.....................................................................................87
8.1.2.1 Respiratory Infections........................................................................................ 88
8.1.2.2 Gastrointestinal Infections ................................................................................. 89
8.1.2.3 Other Infectious Diseases.................................................................................. 90
8.1.3 Rare Diseases..............................................................................................91
8.1.3.1 Inherited Trait Type............................................................................................ 93
8.1.3.2 Acquired Trait Type ........................................................................................... 93
8.1.4 Reproductive Genetics ...............................................................................94
8.1.4.1 Prenatal Diseases.............................................................................................. 95

6. 6
All rights reserved at BIS Research Inc.
G
l
o
b
a
l
D
i
g
i
t
a
l
P
C
R
M
a
r
k
e
t
8.1.4.2 Postnatal Diseases............................................................................................ 95
8.1.5 Gene Expression .........................................................................................96
8.1.6 Other Applications ......................................................................................97
9. End User...................................................................................98
9.1 Overview ......................................................................................................99
9.1.1 Academic and Research Institutions.......................................................100
9.1.2 Hospitals and Clinics ................................................................................101
9.1.3 Diagnostic Centers....................................................................................102
9.1.4 Biopharmaceutical Companies ................................................................102
10. Region .....................................................................................104
10.1 Overview ....................................................................................................105
10.2 North America............................................................................................109
10.2.1 U.S. .......................................................................................................111
10.2.2 Canada .................................................................................................112
10.3 Europe........................................................................................................116
10.3.1 Germany...............................................................................................118
10.3.2 France ..................................................................................................119
10.3.3 U.K........................................................................................................121
10.3.4 Italy.......................................................................................................122
10.3.5 Spain ....................................................................................................124
10.3.6 Rest-of-Europe ....................................................................................125
10.4 Asia-Pacific................................................................................................129
10.4.1 Japan....................................................................................................131
10.4.2 China ....................................................................................................132
10.4.3 Australia...............................................................................................134
10.4.4 South Korea.........................................................................................135
10.4.5 Rest of Asia-Pacific.............................................................................137
10.5 Latin America.............................................................................................139

7. 7
All rights reserved at BIS Research Inc.
G
l
o
b
a
l
D
i
g
i
t
a
l
P
C
R
M
a
r
k
e
t
10.5.1 Brazil ....................................................................................................141
10.5.2 Mexico..................................................................................................142
10.5.3 Rest-of-Latin America.........................................................................144
10.6 Rest-of-the-World (RoW) ..........................................................................145
10.6.1 Middle East ..........................................................................................146
10.6.1.1 K.S.A................................................................................................................ 147
10.6.1.2 Egypt................................................................................................................ 148
10.6.1.3 Rest-of-Middle East ......................................................................................... 148
10.6.2 Africa....................................................................................................149
11. Company Profiles.....................................................................150
11.1 Overview ....................................................................................................151
11.2 Bio-Rad Laboratories, Inc.........................................................................152
11.2.1 Company Overview.............................................................................152
11.2.2 Role of Bio-Rad Laboratories, Inc. in the Global Digital PCR
Market...................................................................................................152
11.2.3 Key Competitors of the Company .....................................................152
11.2.4 Key Customers of the Company........................................................152
11.2.5 Synergistic Activities..........................................................................153
11.2.6 Business Strategies............................................................................153
11.2.6.1 Product Launch/Approval ................................................................................ 153
11.2.7 Financials.............................................................................................154
11.2.8 Analyst Perspective ............................................................................156
11.3 Fluidigm Corporation................................................................................157
11.3.1 Company Overview.............................................................................157
11.3.2 Role of Fluidigm Corporation in the Global d- PCR Market.............157
11.3.3 Key Competitors of the Company .....................................................157
11.3.4 Key Customers of the Company........................................................157
11.3.5 Corporate Strategies...........................................................................158

8. 8
All rights reserved at BIS Research Inc.
G
l
o
b
a
l
D
i
g
i
t
a
l
P
C
R
M
a
r
k
e
t
11.3.5.1 Synergistic Activities........................................................................................ 158
11.3.6 Financials.............................................................................................158
11.3.7 Analyst Perspective ............................................................................160
11.4 F. Hoffmann-La Roche Ltd........................................................................161
11.4.1 Company Overview.............................................................................161
11.4.2 Role of F. Hoffmann-La Roche Ltd. in the Global d-PCR Market ....161
11.4.3 Key Competitors of the Company .....................................................161
11.4.4 Corporate Strategies...........................................................................162
11.4.4.1 Synergistic Activities........................................................................................ 162
11.4.5 Financials.............................................................................................162
11.4.6 Analyst Perspective ............................................................................165
11.5 Merck KGaA...............................................................................................166
11.5.1 Company Overview.............................................................................166
11.5.2 Role of Merck KGaA in the Global Digital PCR Market ....................166
11.5.3 Key Competitors of the Company .....................................................166
11.5.4 Financials.............................................................................................167
11.5.5 Analyst Perspective ............................................................................169
11.6 QIAGEN N.V. ..............................................................................................170
11.6.1 Company Overview.............................................................................170
11.6.2 Role of QIAGEN N.V. in the Global Digital PCR Market ...................170
11.6.3 Key Competitors of the Company .....................................................170
11.6.4 Corporate strategies ...........................................................................171
11.6.4.1 Synergistic Activities........................................................................................ 171
11.6.5 Business Strategies............................................................................172
11.6.5.1 Product Launch/Approval ................................................................................ 172
11.6.6 Financials.............................................................................................172
11.6.7 Analyst Perspective ............................................................................174
11.7 Thermo Fisher Scientific Inc. ...................................................................175

9. 9
All rights reserved at BIS Research Inc.
G
l
o
b
a
l
D
i
g
i
t
a
l
P
C
R
M
a
r
k
e
t
11.7.1 Company Overview.............................................................................175
11.7.2 Role of Thermo Fisher Scientific Inc. in the Global Digital PCR
Market...................................................................................................175
11.7.3 Key Competitors of the Company .....................................................175
11.7.4 Corporate strategies ...........................................................................176
11.7.4.1 Synergistic Activities........................................................................................ 176
11.7.5 Business Strategies............................................................................176
11.7.5.1 Product Launch/Approval ................................................................................ 176
11.7.6 Financials.............................................................................................177
11.7.7 Analyst Perspective ............................................................................179
11.8 Genetron Holdings Limited ......................................................................180
11.8.1 Company Overview.............................................................................180
11.8.2 Role of Genetron Holdings Limited in the Global Digital PCR
Market...................................................................................................180
11.8.3 Key Competitors of the Company .....................................................180
11.8.4 Key Customers of the Company........................................................180
11.8.5 Corporate Strategies...........................................................................181
11.8.5.1 Synergistic Activities........................................................................................ 181
11.8.6 Financials.............................................................................................182
11.8.7 Analyst Perspective ............................................................................183
11.9 JN Medsys .................................................................................................184
11.9.1 Company Overview.............................................................................184
11.9.2 Role of JN Medsys in the Global Digital PCR Market.......................184
11.9.3 Key Competitors of the Company .....................................................184
11.9.4 Analyst Perspective ............................................................................185
11.10 Stilla............................................................................................................186
11.10.1 Company Overview.............................................................................186
11.10.2 Role of Stilla in the Global Digital PCR Market.................................186
11.10.3 Key Competitors of the Company .....................................................186

10. 10
All rights reserved at BIS Research Inc.
G
l
o
b
a
l
D
i
g
i
t
a
l
P
C
R
M
a
r
k
e
t
11.10.4 Corporate Strategies...........................................................................186
11.10.4.1 Synergistic Activities........................................................................................ 186
11.10.5 Business Strategies............................................................................187
11.10.5.1 Product Launch/Approval ................................................................................ 187
11.10.6 Analyst Perspective ............................................................................188
11.11 Naveris, Inc. ...............................................................................................189
11.11.1 Company Overview.............................................................................189
11.11.2 Role of Naveris, Inc. in the Global Digital PCR Market ....................189
11.11.3 Key Competitors of the Company .....................................................189
11.11.4 Corporate strategies ...........................................................................189
11.11.4.1 Synergistic Activities........................................................................................ 189
11.11.5 Analyst Perspective ............................................................................190
11.12 SAGA Diagnostics.....................................................................................191
11.12.1 Company Overview.............................................................................191
11.12.2 Role of SAGA Diagnostics in the Global Digital PCR Market..........191
11.12.3 Key Competitors of the Company .....................................................191
11.12.4 Corporate strategies ...........................................................................191
11.12.4.1 Synergistic Activities........................................................................................ 191
11.12.5 Analyst Perspective ............................................................................192
11.13 Emerging Companies ...............................................................................193
11.13.1 Precigenome LLC................................................................................193
11.13.2 RevoSketch Inc. ..................................................................................193

11. 11
All rights reserved at BIS Research Inc.
G
l
o
b
a
l
D
i
g
i
t
a
l
P
C
R
M
a
r
k
e
t
List of Figures
Figure 1: Global Digital PCR Market (by Product), $Million, 2021 and 2032
Figure 2: Global Digital PCR Market (by Application Type), $Million, 2021 and 2032
Figure 3: Global Digital PCR Market (by Region), $Million, 2021 and 2032
Figure 4: Global Digital PCR Market (by End User), $Million, 2021 and 2032
Figure 5: Global Digital PCR Market Segmentation
Figure 6: Global Digital PCR Market: Research Methodology
Figure 7: Primary Research Methodology
Figure 8: Bottom-Up Approach (Segment-Wise Analysis)
Figure 9: Top-Down Approach (Segment-Wise Analysis)
Figure 10: Evolution of Digital PCR
Figure 11: Global Digital PCR Market, $Million, 2021-2032
Figure 12: Pre-COVID-19 and Post-COVID-19 Scenario of Global Digital PCR Market, $Million, 2019-
2025
Figure 13: Components Considered for Clinical Actionability as per the IVDR
Figure 14: Region-Wise Analysis of Patents, January 2020-July 2022
Figure 15: Country-Wise Analysis of Patents, January 2020-July 2022
Figure 16: Year-Wise Analysis of Patents, January 2020-July 2022
Figure 17: Global Digital PCR Market Dynamics
Figure 18: Likert Scale
Figure 19: Impact Analysis of Market Drivers and Challenges on the Global Digital PCR Market
Figure 20: Share of Key Developments and Strategies, January 2019-January 2022
Figure 21: Share of Mergers and Acquisitions (by Company), January 2019-January 2022
Figure 22: Share of Synergistic Activities (by Company), January 2019-January 2022
Figure 23: Share of Product Launch and Approval Activities (by Company), January 2019-January
2022
Figure 24: Share of Expansion, Funding, and Other Activities (by Company), January 2019-January
2022
Figure 25: Market-Share Analysis for the Global Digital PCR Market, $Million, 2020 and 2021
Figure 26: Growth-Share Analysis of the Global Digital PCR Market (by Company), 2021
Figure 27: Growth-Share Analysis for Digital PCR Market (by Application Type), 2021
Figure 28: Supply Chain Analysis of the Global Digital PCR Market
Figure 29: Global Digital PCR Market (by Product)
Figure 30: Share of Global Digital PCR Market (by Product), $Million, 2021 and 2032
Figure 31: Digital PCR Systems Workflow
Figure 32: Global Digital PCR Market (Systems), $Million, 2021-2032
Figure 33: Sample Partitioning of Droplet Digital PCR System
Figure 34: Global Digital PCR Market (Droplet Digital PCR Systems), $Million, 2021-2032
Figure 35: Workflow of Chip-Based Digital PCR System

12. 12
All rights reserved at BIS Research Inc.
G
l
o
b
a
l
D
i
g
i
t
a
l
P
C
R
M
a
r
k
e
t
Figure 36: Global Digital PCR Market (Chip-Based Digital PCR Systems), $Million, 2021-2032
Figure 37: Global Digital PCR Market (Kits and Assays), $Million, 2021-2032
Figure 38: Global Digital PCR Market (Kits and Assays for Droplet Digital PCR Systems), $Million,
2021-2032
Figure 39: Global Digital PCR Market (Kits and Assays for Chip-Based Digital PCR Systems), $Million,
2021-2032
Figure 40: Global Digital PCR Market (Reagents and Consumables), $Million, 2021-2032
Figure 41: Global Digital PCR Market (Reagents and Consumables for Droplet Digital PCR Systems),
$Million, 2021-2032
Figure 42: Global Digital PCR Market (Reagents and Consumables for Chip-Based Digital PCR),
$Million, 2021-2032
Figure 43: Global Digital PCR Market (by Application Type)
Figure 44: Share of Global Digital PCR Market (by Application Type), $Million, 2021 and 2032
Figure 45: Estimated New Breast Cancer Cases among Female Population
Figure 46: Global Digital PCR Market (Oncology), $Million, 2021-2032
Figure 47: Global Digital PCR Market (Solid Tumor, by Oncology), $Million, 2021-2032
Figure 48: Global Digital PCR Market (Hematologic Malignancies, by Oncology), $Million, 2021-2032
Figure 49: Global Digital PCR Market (Infectious Diseases), $Million, 2021-2032
Figure 50: Distribution of Respiratory Infections
Figure 51: Global Digital PCR Market (Respiratory Infections, by Infectious Diseases), $Million, 2021-
2032
Figure 52: Global Digital PCR Market (Gastrointestinal Infections, by Infectious Diseases), $Million,
2021-2032
Figure 53: Global Digital PCR Market (Other Infectious Diseases, by Infectious Diseases), $Million,
2021-2032
Figure 54: Global Burden of Rare Diseases
Figure 55: Global Digital PCR Market (Rare Diseases), $Million, 2021-2032
Figure 56: Global Digital PCR Market (Inherited Trait Type, by Rare Diseases), $Million, 2021-2032
Figure 57: Global Digital PCR Market (Acquired Trait Type, by Rare Diseases), $Million, 2021-2032
Figure 58: Global Digital PCR Market (Reproductive Genetics), $Million, 2021-2032
Figure 59: Global Digital PCR Market (Prenatal Diseases, by Reproductive Genetics), $Million, 2021-
2032
Figure 60: Global Digital PCR Market (Postnatal Diseases, by Reproductive Genetics), $Million, 2021-
2032
Figure 61: Global Digital PCR Market (Gene Expression), $Million, 2021-2032
Figure 62: Global Digital PCR Market (Other Applications), $Million, 2021-2032
Figure 63: Global Digital PCR Market (by End User)
Figure 64: Share of Global Digital PCR Market (by End User), $Million, 2021 and 2032
Figure 65: Global Digital PCR Market (Academic and Research Institutions), $Million, 2021-2032
Figure 66: Global Digital PCR Market (Hospitals and Clinics), $Million, 2021-2032

13. 13
All rights reserved at BIS Research Inc.
G
l
o
b
a
l
D
i
g
i
t
a
l
P
C
R
M
a
r
k
e
t
Figure 67: Global Digital PCR Market (Diagnostic Centers), $Million, 2021-2032
Figure 68: Global Digital PCR Market (Biopharmaceutical Companies), $Million, 2021-2032
Figure 69: Global Digital PCR Market Snapshot (by Region)
Figure 70: Global Digital PCR Market (by Region), $Million, 2021-2032
Figure 71: Share of Global Digital PCR Market (by Region), $Million, 2021 and 2032
Figure 72: North America Digital PCR Market, $Million, 2021-2032
Figure 73: Growth Potential Analysis (by Country), $Million, 2021-2032
Figure 74: U.S. Digital PCR Market, $Million, 2021-2032
Figure 75: U.S. Digital PCR Market (by End User), $Million, 2021-2032
Figure 76: Canada Digital PCR Market, $Million, 2021-2032
Figure 77: Canada Digital PCR Market (by End User), $Million, 2021-2032
Figure 78: Europe Digital PCR Market, $Million, 2021-2032
Figure 79: Growth Potential Analysis (by Country), $Million, 2021–2032
Figure 80: Germany Digital PCR Market, $Million, 2021-2032
Figure 81: Germany Digital PCR Market (by End User), $Million, 2021-2032
Figure 82: France Digital PCR Market, $Million, 2021-2032
Figure 83: France Digital PCR Market (by End User), $Million, 2021-2032
Figure 84: U.K. Digital PCR Market, $Million, 2021-2032
Figure 85: U.K. Digital PCR Market (by End User), $Million, 2021-2032
Figure 86: Italy Digital PCR Market, $Million, 2021-2032
Figure 87: Italy Digital PCR Market (by End User), $Million, 2021-2032
Figure 88: Spain Digital PCR Market, $Million, 2021-2032
Figure 89: Spain Digital PCR Market (by End User), $Million, 2021-2032
Figure 90: Rest-of-Europe Digital PCR Market, $Million, 2021-2032
Figure 91: Rest-of-Europe Digital PCR Market (by End User), $Million, 2021-2032
Figure 92: Asia-Pacific Digital PCR Market, $Million, 2021-2032
Figure 93: Growth Potential Analysis (by Country), $Million, 2021-2032
Figure 94: Japan Digital PCR Market, $Million, 2021-2032
Figure 95: Japan Digital PCR Market (by End User), $Million, 2021-2032
Figure 96: China Digital PCR Market, $Million, 2021-2032
Figure 97: China Digital PCR Market (by End User), $Million, 2021-2032
Figure 98: Australia Digital PCR Market, $Million, 2021-2032
Figure 99: Australia Digital PCR Market (by End User), $Million, 2021-2032
Figure 100: South Korea Digital PCR Market, $Million, 2021-2032
Figure 101: South Korea Digital PCR Market (by End User), $Million, 2021-2032
Figure 102: Rest-of-Asia-Pacific Digital PCR Market, $Million, 2021-2032
Figure 103: Rest-of-Asia-Pacific Digital PCR Market (by End User), $Million, 2021-2032
Figure 104: Latin America Digital PCR Market, $Million, 2021-2032
Figure 105: Growth Potential Analysis (by Country), $Million, 2021-2032
Figure 106: Brazil Digital PCR Market, $Million, 2021-2032

14. 14
All rights reserved at BIS Research Inc.
G
l
o
b
a
l
D
i
g
i
t
a
l
P
C
R
M
a
r
k
e
t
Figure 107: Brazil Digital PCR Market (by End User), $Million, 2021-2032
Figure 108: Mexico Digital PCR Market, $Million, 2021-2032
Figure 109: Mexico Digital PCR Market (by End User), $Million, 2021-2032
Figure 110: Rest-of-Latin America Digital PCR Market, $Million, 2021-2032
Figure 111: Rest-of-Latin America Digital PCR Market (by End User), $Million, 2021-2032
Figure 112: Rest-of-the-World Digital PCR Market, $Million, 2021-2032
Figure 113: Middle East Digital PCR Market, $Million, 2021-2032
Figure 114: K.S.A. Digital PCR Market, $Million, 2021-2032
Figure 115: Turkey Digital PCR Market, $Million, 2021-2032
Figure 116: Egypt Digital PCR Market, $Million, 2021-2032
Figure 117: Rest-of-Middle East Digital PCR Market, $Million, 2021-2032
Figure 118: Africa Digital PCR Market, $Million, 2021-2032
Figure 119: Total Number of Companies Profiled
Figure 120: Bio-Rad Laboratories, Inc.: Product Portfolio
Figure 121: Bio-Rad Laboratories, Inc.: Overall Financials, $Million, 2019-2021
Figure 122: Bio-Rad Laboratories, Inc.: Revenue (by Segment), $Million, 2019-2021
Figure 123: Bio-Rad Laboratories, Inc.: Revenue (by Region), $Million, 2019-2021
Figure 124: Bio-Rad Laboratories, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 125: Fluidigm Corporation: Product Portfolio
Figure 126: Fluidigm Corporation: Overall Financials, $Million, 2019-2021
Figure 127: Fluidigm Corporation: Revenue (by Region), $Million, 2019-2021
Figure 128: Fluidigm Corporation: R&D Expenditure, $Million, 2019-2021
Figure 129: F. Hoffmann-La Roche Ltd.: Product Portfolio
Figure 130: F. Hoffmann-La Roche Ltd.: Overall Financials, $Million, 2019-2021
Figure 131: F. Hoffmann-La Roche Ltd.: Revenue (by Segment), $Million, 2019-2021
Figure 132: F. Hoffmann-La Roche Ltd.: Revenue (by Region), $Million, 2019-2021
Figure 133: F. Hoffmann-La Roche Ltd.: R&D Expenditure, $Million, 2019-2021
Figure 134: Merck KGaA: Product Portfolio
Figure 135: Merck KGaA: Overall Financials, $Million, 2019-2021
Figure 136: Merck KGaA: Revenue (by Segment), $Million, 2019-2021
Figure 137: Merck KGaA: Revenue (by Region), $Million, 2019-2021
Figure 138: Merck KGaA: R&D Expenditure, $Million, 2019-2021
Figure 139: QIAGEN N.V.: Product Profile
Figure 140: QIAGEN N.V.: Overall Financials, $Million, 2019-2021
Figure 141: QIAGEN N.V.: Revenue (by Segment), $Million, 2019-2021
Figure 142: QIAGEN N.V.: Revenue (by Region), $Million, 2019-2021
Figure 143: QIAGEN N.V.: R&D Expenditure, $Million, 2019-2021
Figure 144: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 145: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2019-2021
Figure 146: Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2019-2021

15. 15
All rights reserved at BIS Research Inc.
G
l
o
b
a
l
D
i
g
i
t
a
l
P
C
R
M
a
r
k
e
t
Figure 147: Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2019-2021
Figure 148: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2019-2021
Figure 149: Genetron Holdings Limited: Product Portfolio
Figure 150: Genetron Holdings Limited: Overall Financials, $Million, 2019-2021
Figure 151: Genetron Holdings Limited: Revenue (by Segment), $Million, 2019-2021
Figure 152: Genetron Holdings Limited: R&D Expenditure, $Million, 2019-2021
Figure 153: JN Medsys: Product Portfolio
Figure 154: Stilla: Product Portfolio
Figure 155: Naveris, Inc.: Product Portfolio
Figure 156: SAGA Diagnostics: Product Portfolio

16. 16
All rights reserved at BIS Research Inc.
G
l
o
b
a
l
D
i
g
i
t
a
l
P
C
R
M
a
r
k
e
t
List of Tables
Table 1: Non-Invasive Prenatal Testing Performance by Digital PCR
Table 2: Advantages of Digital PCR over Conventional PCR
Table 3: Digital PCR Diagnostics Solutions Offered for COVID-19
Table 4: Registration Criteria for IVD Medical Devices as per the CFDA
Table 5: Different Technology-Based Products
Table 6: Different Application-Based Products
Table 7: Companies Providing Digital PCR Systems
Table 8: Companies Providing Droplet Digital PCR Systems
Table 9: Companies Providing Chip-Based Digital PCR Systems
Table 10: Companies Providing Kits and Assays for Digital PCR Systems
Table 11: Companies Providing Reagents and Consumables for Digital PCR Systems
Table 12: Hematologic Malignancies and Their Targets Using Droplet Digital PCR Systems
Table 13: North America: Market Dynamics
Table 14: Europe: Market Dynamics
Table 15: Asia-Pacific: Market Dynamics
Table 16: Latin America: Market Dynamics

17. 17
All rights reserved at BIS Research Inc.
G
l
o
b
a
l
D
i
g
i
t
a
l
P
C
R
M
a
r
k
e
t
Disclaimer
BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to
orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth.
This document and its contents are confidential and may not be further distributed, published or reproduced,
in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS
Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly
through incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information
to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce
Information in legal proceedings.
Market reports are based on expectations, estimates and projections as of the date such information is
available. Any recommendation contained in this report may not be suitable for all investors or businesses.
The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while
considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to
market fluctuations and business, economic and competitive uncertainties and contingencies
For more details regarding permission, please contact us:
Email: sales@bisresearch.com
Tel: +1 510 404 8135

18. 18
All rights reserved at BIS Research Inc.
G
l
o
b
a
l
D
i
g
i
t
a
l
P
C
R
M
a
r
k
e
t
BIS RESEARCH INC.
39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686
E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135
Global Delivery Center
Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway,
Sector 126, Noida, U.P., 201303, India
Tel: +91 120 4261540 / 4261544
www.bisresearch.com